A 28-year-old man with otosclerosis presents with progressive conductive hearing loss and tinnitus. He has declined surgical intervention and wishes to try medical therapy. Which of the following is the preferred first-line pharmacological agent to slow disease progression?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.